Zobrazeno 1 - 10
of 391
pro vyhledávání: '"A. Maj"'
Autor:
Luisa de Siqueira Rotenberg, Hanne Lie Kjærstad, Cristina Varo, Maj Vinberg, Lars Vedel Kessing, Beny Lafer, Kamilla Woznica Miskowiak
Publikováno v:
de Siqueira Rotenberg, L, Kjærstad, H L, Varo, C, Vinberg, M, Kessing, L V, Lafer, B & Miskowiak, K W 2023, ' The longitudinal trajectory of emotional cognition in subgroups of recently diagnosed patients with bipolar disorder ', European Neuropsychopharmacology, vol. 71, pp. 9-24 . https://doi.org/10.1016/j.euroneuro.2023.03.005
Although cross-sectional studies show heterogeneity in emotional cognition in bipolar disorder (BD), the temporal course within subgroups is unclear. In this prospective, longitudinal study we assessed the trajectories of emotional cognition subgroup
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sharleny Stanislaus, Maria Faurholt-Jepsen, Maj Vinberg, Henrik Enghusen Poulsen, Lars V. Kessing, Klara Coello
Publikováno v:
European Neuropsychopharmacology. 62:36-45
Oxidative stress generated nucleoside damage seems to represent key pathophysiological mechanisms of bipolar disorder (BD). Likewise, mood and activity are core features of BD and can be reliably monitored using smartphone-based applications. The aim
Autor:
Danica, Nogo, Ashitija K, Jasrai, Haeun, Kim, Flora, Nasri, Felicia, Ceban, Leanna M W, Lui, Joshua D, Rosenblat, Maj, Vinberg, Roger, Ho, Roger S, McIntyre
Publikováno v:
Psychopharmacology. 239:2011-2039
Anhedonia is a common, persistent, and disabling condition. However, available therapeutics primarily focus on the reduction of depressive and negative symptoms rather than amelioration of deficits in positive affect. As such, extant drug treatments
Autor:
Julian Macoveanu, Johanna Mariegaard, Jeff Zarp Petersen, Patrick M. Fisher, Maj Vinberg, Martin Balslev Jørgensen, Gitte Moos Knudsen, Lars Vedel Kessing, Kamilla Woznica Miskowiak
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry. 125:110767
Autor:
Emilie Poulsen, Iselin Meluken, Eduard Vieta, Maj Vinberg, C. Varo, Kamilla W. Miskowiak, Lars Vedel Kessing, Hanne Lie Kjærstad
Publikováno v:
Varo, C, Kjærstad, H L, Poulsen, E, Meluken, I, Vieta, E, Kessing, L V, Vinberg, M & Miskowiak, K W 2021, ' Emotional cognition subgroups in mood disorders : Associations with familial risk ', European Neuropsychopharmacology, vol. 51, pp. 71-83 . https://doi.org/10.1016/j.euroneuro.2021.05.003
Patients with mood disorders show heterogeneity in non-emotional cognition. However, it is unclear whether emotional cognition (EC) is characterised by similar heterogeneity. We aimed to investigate the heterogeneity in EC among remitted patients wit
Autor:
Lhassane Ismaili, Maciej Maj, Irene Pachón-Angona, Krzysztof Jóźwiak, Artur Wnorowski, Hélène Martin
Publikováno v:
Medical University of Lublin
Background: Alzheimer’s disease is a chronic neurodegenerative chronic disease with a heavy social and economic impact in our developed societies, which still lacks an efficient therapy. Method: This paper describes the Hantzsch multicomponent synt
Autor:
Yanfang Xu, Andrew W. Trafford, Christopher L.-H. Huang, Kevin Zhang, Yanhong Niu, Dan Li, Piotr Maj, David J. Paterson, Lin Wu, Xiaohui Tian, Gongxin Wang, Neil Herring, Luxi Wang, Ming Lei, Chieh-Ju Lu, Yimei Du, Hannali Flores, Xinying Ji, Guoliang Hao, Henggui Zhang
Publikováno v:
ACS Pharmacol Transl Sci
Hydroxychloroquine (HCQ), clinically established in antimalarial and autoimmune therapy, recently raised cardiac arrhythmogenic concerns when used alone or with azithromycin (HCQ+AZM) in Covid-19. We report complementary, experimental, studies of its
Autor:
Maj-Britt Posserud, Joaquin Fuentes, Catherine M. Hill, C. Schroder, Allan Hvolby, Oliviero Bruni, Tobias Banaschewski
Publikováno v:
Expert Opinion on Pharmacotherapy
Schroder, C M, Banaschewski, T, Fuentes, J, Hill, C M, Hvolby, A, Posserud, M B & Bruni, O 2021, ' Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders ', Expert Opinion on Pharmacotherapy, vol. 22, no. 18, pp. 2445-2454 . https://doi.org/10.1080/14656566.2021.1959549
Schroder, C M, Banaschewski, T, Fuentes, J, Hill, C M, Hvolby, A, Posserud, M B & Bruni, O 2021, ' Pediatric prolonged-release melatonin for insomnia in children and adolescents with autism spectrum disorders ', Expert Opinion on Pharmacotherapy, vol. 22, no. 18, pp. 2445-2454 . https://doi.org/10.1080/14656566.2021.1959549
Introduction: Insomnia is common among children and adolescents with Autism spectrum disorder (ASD). The first drug licensed for insomnia in this population, a pediatric-appropriate prolonged-release melatonin (PedPRM) formulation is described. Areas
Autor:
Hanne Lie Kjærstad, Kristine Søhol, Maj Vinberg, Lars Vedel Kessing, Kamilla Woznica Miskowiak
Publikováno v:
Kjærstad, H L, Søhol, K, Vinberg, M, Kessing, L V & Miskowiak, K W 2023, ' The trajectory of emotional and non-emotional cognitive function in newly diagnosed patients with bipolar disorder and their unaffected relatives : A 16-month follow-up study ', European Neuropsychopharmacology, vol. 67, pp. 4-21 . https://doi.org/10.1016/j.euroneuro.2022.11.004
Cognitive impairments are evident in remitted patients with bipolar disorder (BD) and their unaffected relatives (UR) compared to healthy controls (HC). However, the temporal course of cognition, and whether cognition is marked by neuroprogressive ch